Kopran Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: KOPRAN BSE: 524280

About Kopran Limited

No company profile on record yet.

Key facts

BSE symbol524280
NSE symbolKOPRAN
ISININE082A01010
CINL24230MH1958PLC011078
Listing date9 Jun 1999
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorSmita Prabhu & Associates (Smita Prabhu)
Registered officeParijat House, 1076, Dr. E. Moses Road, Worli, Mumbai ��� 400018
Registrar & transfer agentBigshare Services Private Limited Office No S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai ��� 400093

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)309†277†353†290†213†
Net profit3027353112†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Surendra SomaniExecutive DirectorJune 30, 2026
Chandresh Gunvant GandhiIndependent DirectorJune 30, 2026
Mamta Ashok BiyaniIndependent DirectorJune 30, 2026
Narayan Tulsiram AtalIndependent DirectorJune 30, 2026
Namrata Varun SomaniNon-Executive DirectorJune 30, 2026
Varun Surendra SomaniNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.